Cardiometabolic Risk Profile in Acute Coronary Syndrome Patients

1. Grundy SM (2008) Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol 28: 629-636.10.1161/ATVBAHA.107.15109218174459Search in Google Scholar

2. Hossain P, Kawar B, El Nahas M (2007) Obesity and diabetes in the developing world--a growing challenge.N Engl J Med 356: 213-21510.1056/NEJMp06817717229948Search in Google Scholar

3. Ana Jovera, Emili Corbellab, Anna Muñoz Prevalence of Metabolic Syndrome and its Components in Patients With Acute Coronary Syndrome, Revista Espaniola de Cardiologia, pages 579-586 (July 2011)10.1016/j.rec.2011.03.009Search in Google Scholar

4. Victor Blaton, How is the Metabolic Syndrome Related to the Dyslipidemia?, EJIFCC. 2007 Feb; 18(1): 1522Search in Google Scholar

5. Ryan Lahey, Sadiya S. Khan,Trends in Obesity and Risk of Cardiovascular Disease, Curr Epidemiol Rep. 2018 Sep; 5(3): 243251.10.1007/s40471-018-0160-1634939230705802Search in Google Scholar

6. Thang S Han, Mike EJ Lean, A clinical perspective of obesity, metabolic syndrome and cardiovascular disease, JRSM Cardiovasc Dis. 2016 Jan-Dec; 5,10.1177/2048004016633371478007026998259Search in Google Scholar

7. Giuseppe Mulč, Ilenia Calcaterra,, Metabolic syndrome in hypertensive patients: An unholy alliance, World J Cardiol. 2014 Sep 26; 6(9): 890907.10.4330/wjc.v6.i9.890417679925276291Search in Google Scholar

8. Hidekatsu Yanai, Yoshiharu Tomono, The underlying mechanisms for development of hypertension in the metabolic syndrome, Nutr J. 2008; 7: 10.10.1186/1475-2891-7-10233511318416854Search in Google Scholar

9. D Porte JrMechanisms for Hyperglycemia in the Metabolic Syndrome. The Key Role of Beta-Cell Dysfunction, Ann N Y Acad Sci 1999 Nov 18;892:73-8310.1111/j.1749-6632.1999.tb07786.x10842653Search in Google Scholar

10. Abdullah M. Alshehri, Metabolic syndrome and cardiovascular risk, J Family Community Med. 2010 May-Aug; 17(2): 7378.10.4103/1319-1683.71987304509821359028Search in Google Scholar

11. Mottillo S, Filion KB, Genest J, et al. The metabolic syn-drome and cardiovascular risk a systematic review andmeta-analysis.J Am Coll Cardiol2010; 56: 11131132.10.1016/j.jacc.2010.05.03420863953Search in Google Scholar

12. Tune JD, Goodwill AG, Sassoon DJ, Mather KJ. Cardiovascular consequences of metabolic syndrome. Transl Res. 2017;183:5770. doi:10.1016/j.trsl. 2017.01.001Search in Google Scholar

13. Kahn R, Buse J, Ferrannini E, et al. The metabolic syndrome: Time for a critical appraisal: Joint statement fromthe American Diabetes Association and the EuropeanAssociation for the Study of Diabetes.Diabetes Care2005; 28: 22892304Search in Google Scholar

14. Feinberg, M. S., Schwartz, R., & Behar, S. (2008). Impact of Metabolic Syndrome in Patients with Acute Coronary Syndrome. Advances in Cardiology, 114126.10.1159/00011519118230959Search in Google Scholar

15. Marko Mornar Jelavic, Md;, Zdravko Babic, Md, Phd; & Hrvoje Pintaric, Md, Phd Metabolic syndrome: influence on clinical severity and prognosis in patients with acute ST-elevation myocardial infarction treated with primary percutaneous coronary intervention Journal Acta Cardiologica Volume 70, 2015 - Issue 2 P149-15610.1080/AC.70.2.3073505Search in Google Scholar

16. Kazlauskienë, L., Butnorienë, J. & Norkus, A. Metabolic syndrome related to cardiovascular events in a 10-year prospective study. Diabetol Metab Syndr 7, 102 (2015)10.1186/s13098-015-0096-2465390926594246Search in Google Scholar

17. Bundhun, P. K., Wu, Z. J., & Chen, M.-H. (2015). Impact of Modifiable Cardiovascular Risk Factors on Mortality After Percutaneous Coronary Intervention. Medicine, 94(50), e231310.1097/MD.0000000000002313505894226683970Search in Google Scholar